A letter from the Melanoma Research Alliance updating Jeffrey Epstein on the progress of Dr. Ian Watson's research on NF1 mutant melanomas, supported by Epstein's funding. The research aims to identify treatments for melanoma patients with NF1 mutations. Dr. Watson's team has made significant progress, including genetic analysis of melanoma samples and collaboration with oncologists to confirm findings.
documents/EFTA00810760.pdf
{}